This trial is evaluating whether Diet intervention will improve 1 primary outcome and 1 secondary outcome in patients with Hypertriglyceridemia. Measurement will happen over the course of 8 weeks.
This trial requires 40 total participants across 2 different treatment groups
This trial involves 2 different treatments. Diet Intervention is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"In the United States, hypertriglyceridemia is common in people from 4.8 to 29 years old. Higher rates of hypertriglyceridemia and higher total cholesterol levels occur when there is a greater degree of obesity or a lower degree of physical activity." - Anonymous Online Contributor
"There is an urgent need to better define and characterize what causes hypertriglyceridemia in the U.S. and to develop a public education and program to reduce the prevalence of this condition. A national surveillance system is needed to define the prevalence and to determine the causes of elevated levels of this lipid abnormality." - Anonymous Online Contributor
"Hypertriglyceridemia cannot be treated. However, lowering it to a lower target and maintaining it there will result in an improvement to a significant extent, particularly in patients with high levels." - Anonymous Online Contributor
"Hypertriglyceridemia is frequently asymptomatic, and most people would think hypertriglyceridemia may be caused by overweight or obesity, which is the most common cause. It is important to clarify the etiological mechanism of hypertriglyceridemia." - Anonymous Online Contributor
"In contrast to previous reports in the literature using a different methodology, we found no evidence of an increased risk of the development of type 2 diabetes in patients presenting with elevated TG." - Anonymous Online Contributor
"Hypertriglyceridemia is common in the population and not related to a single cause. Hypertriglyceridemia is more common in those who suffer from more severe coronary artery disease and also among smokers." - Anonymous Online Contributor
"No single treatment approach seems superior. In particular, in the short term, weight loss may be effective. But, there is a shortage of trials of long-term treatment options. Meta-analytical techniques are not useful to decide which therapies to use. This report also discusses the controversies in treating hypertriglyceridemia." - Anonymous Online Contributor
"There has been no new discovery of a medication that can help treat the problem of hypertriglyceridemia. There is no compelling evidence that an individual's genetic makeup dictates whether they will develop hypertriglyceridemia and the condition is a huge burden on their lifestyles. Since there is no evidence-based treatment drug for hypertriglyceridemia, it is imperative that we continue to perform research to figure out the cause of the condition, how to prevent and treat individuals, and learn more about the condition as a whole." - Anonymous Online Contributor
"Hypertriglyceridemia is an important factor for cardiovascular diseases, type 2 diabetes, and cardiovascular mortality (Heart Disease and Stroke). Although lipid-lowering therapies have been effective in lowering total cholesterol and LDL levels, they have only limited effects on reducing the risk of heart disease and stroke. The lipid-lowering drugs currently used have not fully resolved the problem of hypertriglyceridemia. New, effective drugs for lipid-lowering therapy are needed." - Anonymous Online Contributor
"As of 2011, no placebo or comparator control studies have been performed for the diet intervention trials of chronic diseases. This may represent one of the biggest gaps in the field of diet-related intervention trials. The following represents a preliminary review of some possible solutions to this problem." - Anonymous Online Contributor
"The diet intervention did not impact on cardiovascular risk factors, lipid profiles, blood cell subtypes, circulating platelet activation markers, platelet function, inflammation, or blood sugar levels in subjects with NRTW. The primary outcome was not superior for subjects with a diet change compared to standard care." - Anonymous Online Contributor
"Despite high adherence, many of the side effects of diet supplementation seem to be unavoidable. These side effects are associated with dietary and metabolic disturbances in the context of an altered insulin metabolism." - Anonymous Online Contributor